Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
A topical antimicrobial combination of **hypochlorous acid** and **acetic acid**. This synergistic formulation is designed to treat wounds and tissue infections, especially those involving microbial biofilms. **Hypochlorous acid** acts as a fast-acting surface-level disinfectant and oxidant, while acetic acid penetrates deeper into tissue, both providing a combined broad-spectrum antibacterial effect. This mixture is employed primarily in the management of wounds, trauma, or skin infections. The combination is formulated at concentrations tailored for either surface disinfection or deeper wound penetration and may be provided in solution, gel, or cream forms. Stabilized hypochlorous acid in acetic acid buffer has shown safety and antimicrobial efficacy in pilot human studies. The primary mechanism involves direct bactericidal action and disruption of microbial biofilm for wound healing augmentation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on hypochlorous acid + acetic acid.